Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Cancer Science|April 17, 2018
Phospholipase D2 promotes disease progression of renal cell carcinoma through the induction of angiogeninShuya Kandori, Takahiro Kojima, Taeko Matsuoka, et al.Scientific Reports|January 22, 2024
Exploratory study of cold hypersensitivity in Japanese women: genetic associations and somatic symptom burdenXuefeng Wu, Tetsuhiro Yoshino, Ayako Maeda-Minami, et al.Oncology Reports|November 21, 2013
Pthlh, a promising cancer modifier gene in rat tongue carcinogenesisHirohiko Suwa, Masato Hirano, Kouji Kawarada, et al.Scientific Reports|February 20, 2021
Effects of maoto (ma-huang-tang) on host lipid mediator and transcriptome signature in influenza virus infectionAkinori Nishi, Noriko Kaifuchi, Chika Shimobori, et al.Journal of Human Genetics|October 20, 2019
Clinical significance of TP53 variants as possible secondary findings in tumor-only next-generation sequencingYoshihiro Yamamoto, Masashi Kanai, Tadayuki Kou, et al.Nature Communications|April 29, 2018
Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 ligand upregulationMana Taki, Kaoru Abiko, Tsukasa Baba, et al.Data in Brief|May 6, 2022
Data of RNA-seq transcriptomes of liver, bone, heart, kidney and blood in klotho mice at a pre-symptomatic state and the effect of a traditional Japanese multi-herbal medicine, juzentaihotoNorihiro Okada, Kenshiro Oshima, Yuki Iwasaki, et al.Gene|June 3, 2021
Intron retention as a new pre-symptomatic marker of aging and its recovery to the normal state by a traditional Japanese multi-herbal medicineNorihiro Okada, Kenshiro Oshima, Yuki Iwasaki, et al.Cancer Science|November 3, 2023
Newly developed preclinical models reveal broad-spectrum CDK inhibitors as potent drugs for CRPC exhibiting primary resistance to enzalutamideTakashi Matsuoka, Aiko Sugiyama, Yoshifumi Miyawaki, et al.Cancer Science|April 26, 2017
Clinical sequencing using a next-generation sequencing-based multiplex gene assay in patients with advanced solid tumorsTadayuki Kou, Masashi Kanai, Yoshihiro Yamamoto, et al.Pageof 3